SUSQUEHANNA INTERNATIONAL GROUP, LLP - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 32 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,630
-24.3%
49,392
+4.8%
0.00%
Q2 2023$39,120
+73.6%
47,121
-24.8%
0.00%
Q1 2023$22,540
+56.8%
62,629
+86.3%
0.00%
Q4 2022$14,37633,6210.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Abingworth LLP 4,822,114$67,027,00015.21%
Column Group LLC 4,309,329$60,546,0006.89%
SECTORAL ASSET MANAGEMENT INC 2,882,744$40,503,0003.37%
Blackstone Inc. 1,308,587$18,386,0000.04%
Virtu Financial LLC 17,444$245,0000.02%
Verition Fund Management LLC 24,667$347,0000.00%
Tower Research Capital LLC (TRC) 6,859$97,0000.00%
CREATIVE FINANCIAL DESIGNS INC /ADV 430$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 24,005$337,0000.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders